Dr. Juliet Beth Del Piero, MD

Dr. Del Piero practices at Juliet Del Piero, M.d., Inc., in Monterey, California.

Dr. Del Piero's NPI, 1568966000, was assigned on March 20, 2018. Dr. Del Piero graduated from Vagelos College of Physicians and Surgeons in 2018. Dr. Del Piero holds California license A180019.

Dr. Del Piero's primary practice is Juliet Del Piero, M.d., Inc.,, at 80 Garden Ct Suite 103 Suite 103, Monterey, CA 93940-5389. The practice phone is (831) 375-2486.

Dr. Del Piero's primary practice is Juliet Del Piero, M.d., Inc., in Monterey, California. Dr. Del Piero is also affiliated with Community Hospital of the Monterey Peninsula. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Del Piero to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Del Piero practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Del Piero's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Del Piero is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Del Piero's licenses on file in 2 states: California and Texas.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Del Piero treats.

CMS data shows 1,059 Medicare services from Dr. Del Piero across 15 procedure codes in 2024, for 378 Medicare patients. Medicare paid $90,982 for them.

CMS counts 378 Medicare patients who saw Dr. Del Piero in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 24% are also on Medicaid. Their average risk score is 0.97, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Del Piero's median patient age at 66, with 59% women.

In 2024, Dr. Del Piero wrote 453 Medicare Part D claims for 138 patients. 57% of them were for generic drugs. CMS names the drug for 366 of them, across 12 drugs with 11 or more claims each, at $20,950 in total drug cost. In 2023, CMS named 151 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Del Piero for performance year 2024, reported as part of a group. Dr. Del Piero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 76 procedures of cataract surgery by Dr. Del Piero, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Del Piero, published from 2022 to 2024. The most frequent topics are Ophthalmologists, Ophthalmology and Optometry. Dr. Del Piero's most frequent co-authors are Ravi Hemant Parikh, MD, Christina Yeeka Weng, MBA, MD and Evan Matthew Chen, MD.

CMS Open Payments shows 10 general payments to Dr. Del Piero from 5 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Glaukos Corporation paid the most, $532.

Dmand AI lists 4 awards for Dr. Del Piero, most recently Everett L Goar Resident Research Award in 2022.

Dr. Del Piero graduated from Vagelos College of Physicians and Surgeons in 2018.

Dr. Del Piero is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.